What is a Good Dose of Ozempic for Weight Loss?

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic and Wegovy, works by slowing stomach emptying and signaling fullness to your brain—but the right dose is different for every person. Most patients begin at 0.25 mg weekly and progress upward over 16–20 weeks, though maintenance doses typically land between 1.0 and 2.4 mg per week. PlexusDx compounds medical-grade semaglutide injections from licensed 503A pharmacies and personalizes your dosing trajectory based on your medical history, metabolic markers, and genetic pathway analysis.

How Semaglutide Dosing Works for Weight Loss

Semaglutide activates GLP-1 receptors in your brain, pancreas, and gut to reduce appetite, slow digestion, and improve blood sugar control. The medication does not work instantly—therapeutic benefit builds over weeks as your body adjusts to each dose level. Standard dosing begins at 0.25 mg once weekly, with increases of 0.25 mg every 4 weeks until reaching a maintenance dose or the highest tolerated level.

Most clinical trials show meaningful weight loss occurs between 1.0 and 2.4 mg weekly, with higher doses delivering greater results in some patients but also higher rates of nausea and gastrointestinal side effects. Your PlexusDx care team monitors your response and side effects at each step, adjusting your timeline or dose strategy to balance efficacy and tolerability. The goal is finding your optimal dose—not the highest dose, but the one that delivers the best weight loss with manageable side effects for your body.

Typical Semaglutide Weight Loss Dose Range

Clinical evidence from GLP-1 trials shows that patients reaching 1.0–2.0 mg weekly experience average weight loss of 10–15% of body weight over 68 weeks, while those reaching 2.4 mg weekly report losses of 15–22%. Doses below 0.5 mg are typically used only during the initial titration phase and rarely produce significant weight loss on their own. Doses above 2.4 mg are not standard for weight loss therapy and carry substantially higher risks of side effects without proven additional benefit.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Why Slow Titration Protects Your Weight Loss Success

Increasing semaglutide too quickly—jumping from 0.25 mg to 1.0 mg in one step, for example—often triggers severe nausea, vomiting, and appetite loss so profound that patients cannot eat or stay hydrated. These side effects frequently cause people to stop the medication entirely, derailing their weight loss journey before it begins. A gradual 4-week titration schedule allows your gut microbiome, appetite hormones, and digestive enzymes to adapt, significantly improving tolerability and long-term adherence.

Research shows that patients who follow a structured titration schedule lose more weight by month 6 than those who experience severe early side effects and discontinue treatment. The slow-dose approach also lets your PlexusDx clinician detect individual sensitivities—such as heightened nausea at certain dose thresholds—and pause or modify your plan accordingly. This personalized pacing is one reason compounded semaglutide from licensed pharmacies, paired with clinical oversight, often outperforms self-managed or rushed dosing strategies.

How PlexusDx Personalizes Your Semaglutide Dosing Plan

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Once you begin treatment, PlexusDx tracks your weekly weight, appetite, energy, and side effect profile through secure check-ins, adjusting your dose schedule if needed. If you experience intolerable nausea at 0.75 mg, your clinician may extend that step by 1–2 weeks before advancing, or may recommend dietary modifications and anti-nausea strategies instead of a standard jump. Your dose may need to go up—your price won't. PlexusDx charges a flat $189 per month for compounded semaglutide injections, regardless of whether you're at 0.25 mg or 2.4 mg weekly, ensuring cost predictability as you find your optimal dose.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the most common maintenance dose of semaglutide for weight loss?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How much weight can I expect to lose on semaglutide?

Clinical trials show patients at 2.4 mg weekly lose 15–22% of their starting body weight over 68 weeks, while those at 1.0–1.5 mg typically lose 10–15%. Results depend on dose, adherence, diet, exercise, and your individual metabolic profile. PlexusDx clinicians set realistic expectations during your initial consultation and track your progress monthly.

How much does PlexusDx compounded semaglutide cost each month?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with no additional per-dose charges as your dose increases. The price remains flat across all dose levels—your dose may need to go up, your price won't. HSA and FSA accounts are accepted, and no insurance or membership fee is required.

What are the most common side effects at different semaglutide doses?

Mild nausea and reduced appetite occur at all doses but are most pronounced when titrating quickly or at higher maintenance levels. Constipation, fatigue, and dry mouth are also common but typically improve within 1–2 weeks as your body adjusts. Severe side effects are rare at proper doses; if they occur, your PlexusDx clinician can pause, reduce, or modify your protocol.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.